Artificial Tendons and Ligaments Market By Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Others), By End users (Hospitals and Clinics, ASCs): Global Opportunity Analysis and Industry Forecast, 2021-2031

Artificial Tendons and Ligaments Market

The artificial tendons and ligaments refer to the surgical replacement of damaged or torn tendons, which are cord-like structures made of strong fibrous connective tissue that connect muscles to bones. Tendons are cable-like tissues that connect muscles to bones. Although one of their functions is to take some of the strain off the muscles, too much activity can injure them. The shoulder, elbow, knee, and ankle joints are most commonly affected by tendon injuries. Artificial tendons and ligament surgeries are preferred for the treatment of tendonitis and damaged tendons and ligaments. Tendinitis occurs when a tendon becomes irritated or inflamed. This can happen through a sudden injury, but it most commonly occurs due to the impact of a minor, repetitious movement. The symptom of tendinitis is pain with any type of movement of the joint especially overhead motions. In a few cases, pain is observed during sleep and early morning hours.

Tendinitis can affect people of any age, especially if they perform a repetitious movement on a regular basis. However, the vast majority of cases occur in people who are at least 40 years old. Elderly individuals have the biggest risk of suffering from chronic tendinitis due to the reduced elasticity in their tendons. Therefore, the rise in geriatric populations drives the growth of the Artificial Tendons Market. For instance, according to the Population Reference Bureau, in July 2019, the number of Americans aged 65 years, or more is projected to double from an estimated 52 million in 2018 to 95 million by 2060.

Growth of the Artificial Tendons And Ligaments Market Size is majorly driven by a rise in the geriatric population, a surge in the number of patients suffering from tendonitis, a rise in physical exercise among children and adults, an increase in interest in professional sports, and surge in a number of athletes that are prone to a tendon injury. Furthermore, the increase in the number of road injuries related to the injury in the tendons is expected to drive market growth. In addition, a rise in R&D investments in drug discovery and development and a rise in occupation-related injury boosts market growth.

For instance, according to the National Library of Medicine, during the 10-year study period, there was an incidence rate of 33.2 injuries per 100,000 person-years. Work-related injuries accounted for 24.9% of acute traumatic tendon injuries. Out of total work-related injuries, occurred in construction and extraction occupations (44.2%), food preparation and serving-related occupations (14.4%), and transportation and material moving occupations (12.5%). Thus, the above-mentioned factors are anticipated to fuel the adoption of such products in the artificial tendons and ligaments industry products.

On the basis of the application of artificial tendons and ligaments, the knee injuries segment generated maximum revenue in 2021 and is expected to witness the highest CAGR during the artificial tendons and ligaments market forecast period, owing to a rise in physical exercise among children and adults, increase in interest of professional sports, and increase in a number of athletes that are prone to knee injuries.

On the basis of end-user, the ambulatory surgery centers (ASCs) segment is expected to witness the highest CAGR during the forecast period, owing to a surge in the number of artificial tendons and ligaments surgeries and an increase in the availability of technically skilled nurses for private practices

Depending on the region, Asia-Pacific Artificial Tendons And Ligaments industry is expected to witness the highest CAGR during the forecast period, owing to the rise in the geriatric population, and emerging economies, and to fulfill the growing demands in developing countries such as India and China.

KEY FINDINGS OF THE STUDY

On the basis of type of application, the knee injuries segment held the largest share in the Artificial Tendons And Ligaments Market Share in 2021 and is expected to remain dominant during the forecast period.

By end users, Artificial Tendons And Ligaments Market Share were dominated by the hospitals and clinics segment in 2021.

On the basis of region, North America held the largest market share in 2021.

The report includes Artificial Tendons And Ligaments Market Analysis of the regional as well as global Artificial Tendons And Ligaments Market trends, key players, market segments, application areas, Growth strategies

Overview

The artificial tendons and ligaments market was valued at $64.3 million in 2021 and is estimated to reach $165.7 million by 2031, growing at a CAGR of 10.1% from 2022 to 2031.

Artificial tendons and ligament tools intended to reinforce or replace natural tendons, and ligaments, including any necessary fixing devices. Artificial tendons are also used to treat torn and damaged tendons. The damaged area may feel weak or painful. Tendons are soft, band-like tissues that connect muscles to bone. Ligaments are fibrous connective tissue that connects one bone to another bone. When the muscles contract, the tendons pull the bones and cause the joints to move. When tendon damage occurs, movement may be seriously limited. The joints that are most commonly affected by tendon injuries are the shoulders, elbows, ankles, thighs, knees, and fingers. According to the American Academy of Orthopedic Surgeons, “jersey finger” is one of the most common sports injuries affecting the tendons. Tendon damage can also occur in rheumatoid arthritis, an inflammatory disease of the joints. Rheumatoid arthritis can involve the tendons, causing them to tear.

The damaged tendon and ligaments can be treated by replacement from artificial tendons and ligaments. The replacement of artificial tendons and ligaments is done to bring back normal movement to a joint. In tendons and ligament surgery, a surgeon will make one or more small incisions (cuts) in the skin over the damaged tendon, replace the damaged tendon or ligament, and sew the torn ends of the tendon together. After, check the surrounding tissue to make sure no other injuries, such as injury to the blood vessels or nerves have occurred, and then close the incision and cover the area with sterile bandages or dressings. After surgery, the surgeon will suggest immobilizing or splinting the joint to allow the tendon to heal.

Major factors driving the growth of the artificial tendons and ligaments market include an increase in the geriatric population, a rise in sports-related injuries such as sprains, strains, tendinitis, and contusions, the surge in incidences of tendon and wrist injuries, and an increase in interest in other workouts and physical activities among children and adults. For instance, according to a John Hopkins Medicine article in 2019, 30 million individuals participate in organized sports, resulting in more than 3.5 million sports injuries annually in the U.S. alone, with sprains and strains.

Tendon injury mostly occurs during hard physical work out such as rowing, heavy weight lifting, occupation activities such as window washing, woodwork, some assembly line works, and sports activities such as football, basketball, pedal cycling, soccer, ice or roller skating, and skateboarding. Artificial muscles and tendons for knee, ankle, and tendon reinforcement will also become increasingly popular due to a growing propensity for minimally invasive procedures, government activities to raise awareness about sports injuries, and developments in surgical methods.

Moreover, the surge in accidents causes tendons and ligament damage, particularly road accidents leading to an increase in the number of artificial tendons and ligament surgeries, thus fueling the growth of the artificial tendons and ligament market. For instance, according to Accident and Emergency (A&E) statistics, 24.8 million sports injuries were recorded in 2019, an increase of 2% compared with 2018. Furthermore, an increase in demand for minimally invasive procedures propels the adoption of artificial tendons and ligaments product.

In addition, technological advancements; the launch of various products; strategies among key players such as acquisition, collaboration, and agreement drive the growth of the artificial tendons and ligaments market

For instance, in 2021, Striker launched its Citrelock tendon fixation devices system for orthopedic surgical applications. The new system provides surgeons with a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, which has unique chemical and mechanical properties for orthopedic surgical applications. The launch of Citrelock will help the company to strengthen its orthopedics portfolio.

However, the lack of acceptance for biological products and the lack of appropriate knowledge regarding products among physicians and surgeons limit the market growth. Stricter regulatory standards and high costs for artificial tendons and ligament products also restrain market growth. Furthermore, the healthcare business is predicted to witness growth, owing to a rise in the prevalence of tendonitis and obesity, an increase in R&D investments in drug discovery & development, and a rise in awareness regarding physical fitness and workout. This is anticipated to offer remunerative opportunities for key players to invest in the market during the forecast period.

The artificial tendons and ligaments market is segmented on the basis of application, end user, and region. On the basis of application, the market is classified into knee Injuries, Shoulder Injuries, foot and ankle injuries, and others. Depending on the end user, it is segmented into hospitals and clinics, and ambulatory surgery centers. The artificial tendons and ligaments market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major players profiled in the report are Artelon, Arthrex, Inc., Corin Group, Enovis, Exactech, Inc., FX-Global Inc., Group FH Communication, Integra Lifesciences, Neoligaments, Stryker Corporation.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the artificial tendons and ligaments market analysis from 2021 to 2031 to identify the prevailing artificial tendons and ligaments market opportunities.

Market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

An in-depth analysis of the artificial tendons and ligaments market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes analysis of the regional as well as global artificial tendons and ligaments market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Stryker Corporatio

Scope of Artificial Tendons and Ligaments Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Knee Injuries

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market share analysis by country

4.3 Shoulder Injuries

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market share analysis by country

4.4 Foot and Ankle Injuries

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market share analysis by country

4.5 Others

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market share analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Hospitals and Clinics

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market share analysis by country

5.3 ASCs

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market share analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key trends and opportunities

6.2.2 North America Market size and forecast, by Application

6.2.3 North America Market size and forecast, by End users

6.2.4 North America Market size and forecast, by country

6.2.4.1 U.S.

6.2.4.1.1 Key market trends, growth factors and opportunities

6.2.4.1.2 Market size and forecast, by Application

6.2.4.1.3 Market size and forecast, by End users

6.2.4.2 Canada

6.2.4.2.1 Key market trends, growth factors and opportunities

6.2.4.2.2 Market size and forecast, by Application

6.2.4.2.3 Market size and forecast, by End users

6.2.4.3 Mexico

6.2.4.3.1 Key market trends, growth factors and opportunities

6.2.4.3.2 Market size and forecast, by Application

6.2.4.3.3 Market size and forecast, by End users

6.3 Europe

6.3.1 Key trends and opportunities

6.3.2 Europe Market size and forecast, by Application

6.3.3 Europe Market size and forecast, by End users

6.3.4 Europe Market size and forecast, by country

6.3.4.1 Germany

6.3.4.1.1 Key market trends, growth factors and opportunities

6.3.4.1.2 Market size and forecast, by Application

6.3.4.1.3 Market size and forecast, by End users

6.3.4.2 France

6.3.4.2.1 Key market trends, growth factors and opportunities

6.3.4.2.2 Market size and forecast, by Application

6.3.4.2.3 Market size and forecast, by End users

6.3.4.3 UK

6.3.4.3.1 Key market trends, growth factors and opportunities

6.3.4.3.2 Market size and forecast, by Application

6.3.4.3.3 Market size and forecast, by End users

6.3.4.4 Italy

6.3.4.4.1 Key market trends, growth factors and opportunities

6.3.4.4.2 Market size and forecast, by Application

6.3.4.4.3 Market size and forecast, by End users

6.3.4.5 Spain

6.3.4.5.1 Key market trends, growth factors and opportunities

6.3.4.5.2 Market size and forecast, by Application

6.3.4.5.3 Market size and forecast, by End users

6.3.4.6 Rest of Europe

6.3.4.6.1 Key market trends, growth factors and opportunities

6.3.4.6.2 Market size and forecast, by Application

6.3.4.6.3 Market size and forecast, by End users

6.4 Asia-Pacific

6.4.1 Key trends and opportunities

6.4.2 Asia-Pacific Market size and forecast, by Application

6.4.3 Asia-Pacific Market size and forecast, by End users

6.4.4 Asia-Pacific Market size and forecast, by country

6.4.4.1 Japan

6.4.4.1.1 Key market trends, growth factors and opportunities

6.4.4.1.2 Market size and forecast, by Application

6.4.4.1.3 Market size and forecast, by End users

6.4.4.2 China

6.4.4.2.1 Key market trends, growth factors and opportunities

6.4.4.2.2 Market size and forecast, by Application

6.4.4.2.3 Market size and forecast, by End users

6.4.4.3 India

6.4.4.3.1 Key market trends, growth factors and opportunities

6.4.4.3.2 Market size and forecast, by Application

6.4.4.3.3 Market size and forecast, by End users

6.4.4.4 Australia

6.4.4.4.1 Key market trends, growth factors and opportunities

6.4.4.4.2 Market size and forecast, by Application

6.4.4.4.3 Market size and forecast, by End users

6.4.4.5 South Korea

6.4.4.5.1 Key market trends, growth factors and opportunities

6.4.4.5.2 Market size and forecast, by Application

6.4.4.5.3 Market size and forecast, by End users

6.4.4.6 Rest of Asia-Pacific

6.4.4.6.1 Key market trends, growth factors and opportunities

6.4.4.6.2 Market size and forecast, by Application

6.4.4.6.3 Market size and forecast, by End users

6.5 LAMEA

6.5.1 Key trends and opportunities

6.5.2 LAMEA Market size and forecast, by Application

6.5.3 LAMEA Market size and forecast, by End users

6.5.4 LAMEA Market size and forecast, by country

6.5.4.1 Brazil

6.5.4.1.1 Key market trends, growth factors and opportunities

6.5.4.1.2 Market size and forecast, by Application

6.5.4.1.3 Market size and forecast, by End users

6.5.4.2 South Africa

6.5.4.2.1 Key market trends, growth factors and opportunities

6.5.4.2.2 Market size and forecast, by Application

6.5.4.2.3 Market size and forecast, by End users

6.5.4.3 Saudi Arabia

6.5.4.3.1 Key market trends, growth factors and opportunities

6.5.4.3.2 Market size and forecast, by Application

6.5.4.3.3 Market size and forecast, by End users

6.5.4.4 Rest of LAMEA

6.5.4.4.1 Key market trends, growth factors and opportunities

6.5.4.4.2 Market size and forecast, by Application

6.5.4.4.3 Market size and forecast, by End users

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Key developments

8.1 Arthrex, Inc.

8.1.1 Company overview

8.1.2 Company snapshot

8.1.3 Operating business segments

8.1.4 Product portfolio

8.1.5 Business performance

8.1.6 Key strategic moves and developments

8.2 fx solutions

8.2.1 Company overview

8.2.2 Company snapshot

8.2.3 Operating business segments

8.2.4 Product portfolio

8.2.5 Business performance

8.2.6 Key strategic moves and developments

8.3 Orthomed S.A.S

8.3.1 Company overview

8.3.2 Company snapshot

8.3.3 Operating business segments

8.3.4 Product portfolio

8.3.5 Business performance

8.3.6 Key strategic moves and developments

8.4 Neoligaments

8.4.1 Company overview

8.4.2 Company snapshot

8.4.3 Operating business segments

8.4.4 Product portfolio

8.4.5 Business performance

8.4.6 Key strategic moves and developments

8.5 Artelon

8.5.1 Company overview

8.5.2 Company snapshot

8.5.3 Operating business segments

8.5.4 Product portfolio

8.5.5 Business performance

8.5.6 Key strategic moves and developments

8.6 Corin Groups

8.6.1 Company overview

8.6.2 Company snapshot

8.6.3 Operating business segments

8.6.4 Product portfolio

8.6.5 Business performance

8.6.6 Key strategic moves and developments

8.7 Mathys AG

8.7.1 Company overview

8.7.2 Company snapshot

8.7.3 Operating business segments

8.7.4 Product portfolio

8.7.5 Business performance

8.7.6 Key strategic moves and developments

8.8 F H Orthopedics

8.8.1 Company overview

8.8.2 Company snapshot

8.8.3 Operating business segments

8.8.4 Product portfolio

8.8.5 Business performance

8.8.6 Key strategic moves and developments

8.9 Integra Lifesciences Corporation

8.9.1 Company overview

8.9.2 Company snapshot

8.9.3 Operating business segments

8.9.4 Product portfolio

8.9.5 Business performance

8.9.6 Key strategic moves and developments

8.10 Stryker Corporation

8.10.1 Company overview

8.10.2 Company snapshot

8.10.3 Operating business segments

8.10.4 Product portfolio

8.10.5 Business performance

8.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 2. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR KNEE INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 3. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR KNEE INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 4. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR SHOULDER INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 5. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR SHOULDER INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 6. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR FOOT AND ANKLE INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 7. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR FOOT AND ANKLE INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 8. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 9. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 10. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 11. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 12. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 13. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR ASCS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 14. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR ASCS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 15. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 16. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 17. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 18. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 19. U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 20. U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 21. CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 22. CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 23. MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 24. MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 25. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 26. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 27. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 28. GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 29. GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 30. FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 31. FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 32. UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 33. UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 34. ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 35. ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 36. SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 37. SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 38. REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 39. REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 40. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 41. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 42. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 43. JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 44. JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 45. CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 46. CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 47. INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 48. INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 49. AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 50. AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 51. SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 52. SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 53. REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 54. REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 55. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 56. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 57. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 58. BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 59. BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 60. SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 61. SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 62. SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 63. SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 64. REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 65. REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)

TABLE 66.ARTHREX, INC.: COMPANY SNAPSHOT

TABLE 67.ARTHREX, INC.: OPERATING SEGMENTS

TABLE 68.ARTHREX, INC.: PRODUCT PORTFOLIO

TABLE 69.ARTHREX, INC.: NET SALES

TABLE 70.ARTHREX, INC.: KEY STRATERGIES

TABLE 71.FX SOLUTIONS: COMPANY SNAPSHOT

TABLE 72.FX SOLUTIONS: OPERATING SEGMENTS

TABLE 73.FX SOLUTIONS: PRODUCT PORTFOLIO

TABLE 74.FX SOLUTIONS: NET SALES

TABLE 75.FX SOLUTIONS: KEY STRATERGIES

TABLE 76.ORTHOMED S.A.S: COMPANY SNAPSHOT

TABLE 77.ORTHOMED S.A.S: OPERATING SEGMENTS

TABLE 78.ORTHOMED S.A.S: PRODUCT PORTFOLIO

TABLE 79.ORTHOMED S.A.S: NET SALES

TABLE 80.ORTHOMED S.A.S: KEY STRATERGIES

TABLE 81.NEOLIGAMENTS: COMPANY SNAPSHOT

TABLE 82.NEOLIGAMENTS: OPERATING SEGMENTS

TABLE 83.NEOLIGAMENTS: PRODUCT PORTFOLIO

TABLE 84.NEOLIGAMENTS: NET SALES

TABLE 85.NEOLIGAMENTS: KEY STRATERGIES

TABLE 86.ARTELON: COMPANY SNAPSHOT

TABLE 87.ARTELON: OPERATING SEGMENTS

TABLE 88.ARTELON: PRODUCT PORTFOLIO

TABLE 89.ARTELON: NET SALES

TABLE 90.ARTELON: KEY STRATERGIES

TABLE 91.CORIN GROUPS: COMPANY SNAPSHOT

TABLE 92.CORIN GROUPS: OPERATING SEGMENTS

TABLE 93.CORIN GROUPS: PRODUCT PORTFOLIO

TABLE 94.CORIN GROUPS: NET SALES

TABLE 95.CORIN GROUPS: KEY STRATERGIES

TABLE 96.MATHYS AG: COMPANY SNAPSHOT

TABLE 97.MATHYS AG: OPERATING SEGMENTS

TABLE 98.MATHYS AG: PRODUCT PORTFOLIO

TABLE 99.MATHYS AG: NET SALES

TABLE 100.MATHYS AG: KEY STRATERGIES

TABLE 101.F H ORTHOPEDICS: COMPANY SNAPSHOT

TABLE 102.F H ORTHOPEDICS: OPERATING SEGMENTS

TABLE 103.F H ORTHOPEDICS: PRODUCT PORTFOLIO

TABLE 104.F H ORTHOPEDICS: NET SALES

TABLE 105.F H ORTHOPEDICS: KEY STRATERGIES

TABLE 106.INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT

TABLE 107.INTEGRA LIFESCIENCES CORPORATION: OPERATING SEGMENTS

TABLE 108.INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO

TABLE 109.INTEGRA LIFESCIENCES CORPORATION: NET SALES

TABLE 110.INTEGRA LIFESCIENCES CORPORATION: KEY STRATERGIES

TABLE 111.STRYKER CORPORATION: COMPANY SNAPSHOT

TABLE 112.STRYKER CORPORATION: OPERATING SEGMENTS

TABLE 113.STRYKER CORPORATION: PRODUCT PORTFOLIO

TABLE 114.STRYKER CORPORATION: NET SALES

TABLE 115.STRYKER CORPORATION: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.ARTIFICIAL TENDONS AND LIGAMENTS MARKET SEGMENTATION

FIGURE 2.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031

FIGURE 3.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.ARTIFICIAL TENDONS AND LIGAMENTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,BY APPLICATION,2021(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF KNEE INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SHOULDER INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FOOT AND ANKLE INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)

FIGURE 17.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,BY END USERS,2021(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ASCS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)

FIGURE 20.ARTIFICIAL TENDONS AND LIGAMENTS MARKET BY REGION,2021

FIGURE 21.U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 22.CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 23.MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 24.GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 25.FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 26.UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 27.ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 28.SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 29.REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 30.JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 31.CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 32.INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 33.AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 34.SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 35.REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 36.BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 37.SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 38.SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 39.REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)

FIGURE 40. TOP WINNING STRATEGIES, BY YEAR

FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 44.COMPETITIVE DASHBOARD

FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 46.ARTHREX, INC..: NET SALES ($MILLION)

FIGURE 47.FX SOLUTIONS.: NET SALES ($MILLION)

FIGURE 48.ORTHOMED S.A.S.: NET SALES ($MILLION)

FIGURE 49.NEOLIGAMENTS.: NET SALES ($MILLION)

FIGURE 50.ARTELON.: NET SALES ($MILLION)

FIGURE 51.CORIN GROUPS.: NET SALES ($MILLION)

FIGURE 52.MATHYS AG.: NET SALES ($MILLION)

FIGURE 53.F H ORTHOPEDICS.: NET SALES ($MILLION)

FIGURE 54.INTEGRA LIFESCIENCES CORPORATION.: NET SALES ($MILLION)

FIGURE 55.STRYKER CORPORATION.: NET SALES ($MILLION